Moore W S
Department of Surgery, UCLA School of Medicine, USA.
Cardiovasc Surg. 1995 Apr;3(2):109-14. doi: 10.1016/0967-2109(95)90882-6.
The objective of this report is to review the author's initial clinical experience with screening a population of patients with abdominal aortic aneurysm, to describe the selection criteria for endovascular repair and to report results from a single institution. The technique of transfemoral repair of abdominal aortic aneurysm uses the endovascular graft system that is currently in a Food and Drugs Administration approved protocol for investigation in the United States. Some 69 patients with abdominal aortic aneurysm were screened in order to find ten suitable candidates. Ten implantations were carried out, of which eight were successful and two required conversion to conventional open aneurysm repair without complication. There were no deaths or complications. It is concluded that tube graft repair by the transfemoral route is feasible and applicable to approximately one patient in seven. The availability of a bifurcated graft will enhance the percentage of aneurysm patients treatable by this technique. Long-term results, at this time, are unknown.
本报告的目的是回顾作者对腹主动脉瘤患者群体进行筛查的初步临床经验，描述血管内修复的选择标准，并报告来自单一机构的结果。腹主动脉瘤经股动脉修复技术使用的血管内移植物系统目前正处于美国食品药品监督管理局批准的研究方案中。为了找到十名合适的候选人，对约69例腹主动脉瘤患者进行了筛查。进行了十次植入手术，其中八次成功，两次需要转为传统的开放性动脉瘤修复且无并发症。没有死亡或并发症发生。得出的结论是，经股动脉途径的管状移植物修复是可行的，大约每七名患者中就有一名适用。分叉移植物的可用性将提高可通过该技术治疗的动脉瘤患者的比例。目前，长期结果尚不清楚。
